Iman Dajani

Ms. Iman Dajani

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2026 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
IDIman Dajani
Iman Dajani
MEMaria Christina Esteban
Maria Christina Esteban
ACAli CHAARI
Ali CHAARI
Background: Understanding protein structure is foundational to preclinical medical education and underpins later learning in hematology, physiology, and pharmacology. However, many biochemical concepts, particularly those involving three-dimensional molecular architecture, are difficult for students to conceptualize using traditional two-dimensional instructional tools. Immersive virtual reality (VR) enables interactive, stereoscopic visualization of biomolecules and may support spatial understanding of complex protein structures. This study aimed to evaluate undergraduate preclinical medical students’ self-reported perceptions of learning, spatial understanding, and engagement following a VR-based instructional session focused on hemoglobin structure. Methods & data analysis: In this mixed-methods study, a retrospective within-session pre/post evaluation was embedded within a preclinical medical biochemistry course at Weill Cornell Medicine-Qatar. Students used the Nanome platform on standalone VR headsets to explore hemoglobin’s quaternary structure, heme coordination, and conformational transitions. Quantitative outcomes were assessed using three 10-point Likert-scale items administered before and after the session. Qualitative data were collected through open-ended survey questions and analyzed thematically. Results: Fifty-four students participated. Following the VR session, a larger proportion of students selected the highest rating categories for perceived usefulness of VR (63%), spatial understanding of hemoglobin (66.7%), and overall structural understanding (70.5%). Overall responses reflected consistently positive self-reported perceptions of learning and visualization. Mild discomfort related to headset use was reported by a minority of participants (35 none, 13 transient, 6 persistent). Qualitative feedback highlighted clearer subunit differentiation, improved visualization of the heme environment, and collaborative discussion. Conclusions: VR-based molecular visualization was associated with consistently positive student-reported perceptions of spatial understanding and engagement in preclinical biochemistry education. These findings suggest that immersive VR may serve as a feasible adjunct to conventional instructional methods for teaching spatially complex molecular concepts.

23 August 2026 in Obesity Reviews
Verified
Journal Article
Open access
PDF file
PPPradipta Paul
Pradipta Paul
IDIman Dajani
Iman Dajani
RKRidhima Kaul
Ridhima Kaul
ACAli CHAARI
Ali CHAARI
Background: Metabolic syndrome (MetS) is a prevalent cardiometabolic disorder characterized by central obesity, insulin resistance, dyslipidemia, and hypertension. Microbiome‐targeted therapies with probiotics, prebiotics, and synbiotics may improve outcomes by modulating metabolism, inflammation, and blood pressure. Methods: We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs) in adults with MetS. Searches through April 2023 identified eligible RCTs, yielding 19 studies and 21 independent comparisons. Pooled mean differences (MDs) with 95% confidence intervals (CIs) were calculated using a random effects model. Subgroup analyses and meta‐regressions examined moderators and heterogeneity. Results: A total of 19 studies comprising 21 trial comparisons were included. Microbiome‐modulating interventions were associated with modest reductions in waist circumference and body weight (BW), indicating improvements in central adiposity. In contrast, effects on body mass index (BMI) were limited, and no meaningful changes were observed in systolic or diastolic blood pressure (DBP). Subgroup and meta‐regression analyses suggested that higher microbial dose, longer intervention duration, and greater baseline adiposity were associated with more pronounced anthropometric responses. Moderate heterogeneity was observed across several outcomes. Conclusions: Microbiome‐targeted therapies reduced waist circumference (WC) and BW in MetS but had no effect on BMI, systolic blood pressure (SBP), or DBP. These safe interventions may complement lifestyle strategies. Larger, standardized trials with microbiome profiling are needed to refine therapeutic use. These findings support a potential adjunctive role for microbiome‐targeted therapies in MetS, particularly for central adiposity, though standardized, longer duration trials with microbiome profiling are needed to clarify clinical utility.

28 April 2026 in Tomography
Verified
Journal Article
Open access
PDF file
SAShahd Aljoudi
Shahd Aljoudi
AKAasiya Khan
Aasiya Khan
IDIman Dajani
Iman Dajani
MAMinatullah Al-Ani
Minatullah Al-Ani
MMMichael Mina
Michael Mina
MYMohammad Yousef
Mohammad Yousef
Background/Objectives: Prostate cancer (PCa) is the second most commonly diagnosed cancer in men globally. Radiation oncologists often find PCa tumor characterization and outcome prediction challenging. Therefore, the potential for artificial intelligence (AI) implementation in radiation oncology has increased in recent years. This systematic review aims to evaluate the efficacy of AI algorithms in characterizing PCa tumors and predicting post-therapy outcomes. Methods: A total of 2055 studies were identified through a comprehensive search across PubMed and Scopus, then exported to Covidence. Inclusion criteria focused on prospective and retrospective cohort studies as well as randomized clinical trials (RCTs) published between 2015 and 2024 that explored the implementation of AI in tumor characterization and outcome prediction of PCa. Two independent reviewers evaluated each paper, and evaluation metrics such as specificity, sensitivity, accuracy, and area under the curve (AUC) were analyzed. The Risk of Bias in Non-randomized Studies of Interventions, Version 2 (ROBINS-I V2) tool was used to assess the risk of bias (ROB). Results: Across the 19 studies analyzed, there was no significant difference in model performance between machine learning (ML) and deep learning (DL) models. AI models using multi-input strategies (e.g., radiomics with clinical markers) generally performed better than single-input models. Of the imaging modalities used for radiomic feature extraction, multiparametric MRI (mpMRI)-trained AI models consistently achieved the highest performance. Conclusions: AI displays considerable potential for integration into clinical workflows for PCa management. However, further studies utilizing larger datasets and external cohorts independent of the sample population are needed to validate clinical utility and improve model transparency for reliable implementation.

17 July 2026 in Journal of Global Health
Verified
Journal Article
Open access
IDIman Dajani
Iman Dajani
AMAnns Mahboob
Anns Mahboob
SIShahad Sabaawi Ibrahim
Shahad Sabaawi Ibrahim
RIRaghad Sabawi Ibrahim
Raghad Sabawi Ibrahim
MSMohsen Sedighi
Mohsen Sedighi
NANAWAF AHMAD M S AL-MUHANNADI
NAWAF AHMAD M S AL-MUHANNADI
Dementia prevalence in the Middle East and North Africa (MENA) is projected to rise exponentially, with estimates suggesting increases of 367% by 2050. This region faces distinctive challenges, including rapid demographic transition, high rates of modifiable risk factors, and fragmented health systems. This paper examines region-specific risk factors and pooled prevalence rates of dementia across the MENA region. We conducted a narrative review of dementia risk factors in the MENA region, including analysis of population-attributable risk (PAR) estimates and pooled estimates of dementia prevalence among adults aged 50 years and older. Dementia prevalence was estimated at 1.84% among individuals aged 50 years and older, increasing to 3.81% among those aged 60 years and older, with substantial variability across countries. Smoking (>30%), physical inactivity ( ~ 50%), and high burdens of diabetes, hypertension, and obesity were consistently associated with increased dementia risk. Additional region-specific drivers include nutritional transitions, gut dysbiosis, consanguinity, and environmental risk factors such as air pollution and climate-related heat stress. Critical barriers to prevention and care include limited research infrastructure, low health literacy, stigma, and inequitable health care access. Dementia prevalence in MENA is rising rapidly, driven by demographic change and high exposure to modifiable risk factors that are relatively region-specific in terms of their contribution. Strengthening prevention, early detection, and equitable access to care should be regional health priorities.